IACH Journal Club-Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial – Monday, March 24, 2025
Open to access this content
0.5 Credit
How to Get Published: a Few Tips
Open to access this content
How to Get Published: a Few Tips Read More »
Management of Waldenström’s Disease: An Update
Open to access this content
Management of Waldenström’s Disease: An Update Read More »
Transplant Indications in Lymphoma: Where Are We?
Open to access this content
Transplant Indications in Lymphoma: Where Are We? Read More »
CAR T-cells for AML: Where do we stand?
Open to access this content
CAR T-cells for AML: Where do we stand? Read More »
Management of AL amyloidosis : an update
Open to access this content
Management of AL amyloidosis : an update Read More »
